FDA Inspection
Ingenus Pharmaceuticals NJ, LLC.Ingenus Pharmaceuticals NJ, LLC. – FDA Inspection, Sep 27, 2017
Record Details
This FDA Inspection record concerns Ingenus Pharmaceuticals NJ, LLC., with an inspection on September 27, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · fe279523-321a-41c0-818b-f4219e00517d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1026727
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Ingenus Pharmaceuticals NJ, LLC.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| July 17, 2026 | Not classified | New Jersey District Office | Compliance: Devices |
| January 9, 2026 | Not classified | New Jersey District Office | |
| February 18, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 24, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 14, 2017 | VAI | New Jersey District Office | Generic Drug Evaluation |
Other documents for Ingenus Pharmaceuticals NJ, LLC.
- FDA Inspection 1326668 - 2026-07-17
- FDA Inspection 1302128 - 2026-01-09
- FDA Inspection 1164226 - 2022-02-18
- FDA Inspection 1079060 - 2019-01-24
- FDA Inspection 1035002 - 2017-12-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.